RAAB MICHAEL
President & CEO
Sale 10b5-1
- Shares
- 41,668
- Price
- $5.06
- Value
- $210,923
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•67 filings
ARDX
ARDELYX, INC.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$1,946,331
1 distinct insiders
12-month sales
$2,314,174
2 distinct insiders
Highlighted alerts
1
10 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get ARDX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
ARDX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
11
Voluntary view
P/S trades after deterministic checks
92
Administrative noise
Stored, never alerted
21
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 1,558
- Price
- $3.86
- Footnotes
- 1
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Williams Laura A
Chief Patient Officer
Sale 10b5-1
- Shares
- 81,898
- Price
- $5.99
- Value
- $490,487
RAAB MICHAEL
President & CEO
Sale 10b5-1
- Shares
- 41,666
- Price
- $5.67
- Value
- $236,346
RAAB MICHAEL
President & CEO
Sale 10b5-1
- Shares
- 41,666
- Price
- $6.28
- Value
- $261,612
RAAB MICHAEL
President & CEO
Sale 10b5-1
- Shares
- 41,668
- Price
- $6.29
- Value
- $261,954
RAAB MICHAEL
President & CEO
Sale 10b5-1
- Shares
- 41,666
- Price
- $5.84
- Value
- $243,329
RAAB MICHAEL
President & CEO
Sale 10b5-1
- Shares
- 41,666
- Price
- $6.26
- Value
- $260,621
MOTT DAVID M
Director
PurchaseAlert
- Shares
- 333,333
- Price
- $5.84
- Value
- $1,946,331
Williams Laura A
Chief Patient Officer
Sale 10b5-1
- Shares
- 50,000
- Price
- $6.98
- Value
- $348,900
Williams Laura A
Chief Patient Officer
Sale 10b5-1
- Shares
- 30,000
- Price
- $6.12
- Value
- $183,630
Williams Laura A
Chief Patient Officer
Sale 10b5-1
- Shares
- 50,000
- Price
- $6.12
- Value
- $306,050
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | RAAB MICHAEL President & CEO | Sale | 41,668 | $5.06 | $210,923 | |
| Jun 18, 2026 | Williams Laura A Chief Patient Officer | Sale | 81,898 | $5.99 | $490,487 | |
| Jun 15, 2026 | RAAB MICHAEL President & CEO | Sale | 41,666 | $5.67 | $236,346 | |
| May 15, 2026 | RAAB MICHAEL President & CEO | Sale | 41,666 | $6.28 | $261,612 | |
| Apr 15, 2026 | RAAB MICHAEL President & CEO | Sale | 41,668 | $6.29 | $261,954 | |
| Mar 16, 2026 | RAAB MICHAEL President & CEO | Sale | 41,666 | $5.84 | $243,329 | |
| Feb 24, 2026 | RAAB MICHAEL President & CEO | Sale | 41,666 | $6.26 | $260,621 | |
| Feb 20, 2026 | MOTT DAVID M Director | Purchase | 333,333 | $5.84 | $1,946,331 | |
| Jan 08, 2026 | Williams Laura A Chief Patient Officer | Sale | 50,000 | $6.98 | $348,900 | |
| Aug 26, 2025 | Williams Laura A Chief Patient Officer | Sale | 30,000 | $6.12 | $183,630 | |
| Aug 26, 2025 | Williams Laura A Chief Patient Officer | Sale | 50,000 | $6.12 | $306,050 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.